Armata Pharmaceuticals, INC. (ARMP) SEC Filings — 2025

Filings

• Armata Pharmaceuticals, INC. 8-K Filing — 8-K · Dec 1, 2025
• Armata's Net Loss Doubles to $49.5M, Raising Going Concern Doubts — 10-Q · Nov 12, 2025
• Armata Pharmaceuticals Files 8-K — 8-K · Oct 22, 2025
• Armata Pharmaceuticals Files 8-K — 8-K · Sep 11, 2025
• Armata's Q2 Loss Widens Amidst R&D Spend, Secures New Loan — 10-Q · Aug 12, 2025
• Armata Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Jun 13, 2025
• Armata Pharmaceuticals Files 8-K — 8-K · May 19, 2025
• Armata Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 14, 2025
• Armata Pharmaceuticals Files 8-K — 8-K · May 1, 2025
• Armata Pharmaceuticals Files Proxy Statement for June 12 Meeting — DEF 14A · Apr 28, 2025
• Merck to Acquire Armata Pharmaceuticals for $1.7B — 8-K · Apr 2, 2025
• Armata Pharmaceuticals Files 2024 10-K — 10-K · Mar 21, 2025
• Armata Pharmaceuticals Files 8-K: Material Agreement & Financial Obligation — 8-K · Mar 12, 2025